Outer membrane vesicles as acellular vaccine against pertussis

R Roberts, G Moreno, D Bottero, ME Gaillard… - Vaccine, 2008 - Elsevier
In this study the development and evaluation of outer membrane vesicles (OMVs) obtained
from Bordetella pertussis as vaccines against pertussis disease is described. SDS-PAGE …

A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents

LA Jackson, RM Jacobson, KS Reisinger… - The Pediatric …, 2009 - journals.lww.com
Background: Because of the well-documented increased risk of meningococcal disease
among adolescents, vaccination is recommended for this population in many countries …

Cost-effectiveness of adolescent pertussis vaccination for the Netherlands: using an individual-based dynamic model

R de Vries, M Kretzschmar, JFP Schellekens… - PloS one, 2010 - journals.plos.org
Background Despite widespread immunization programs, a clear increase in pertussis
incidence is apparent in many developed countries during the last decades. Consequently …

Modelling the impact of extended vaccination strategies on the epidemiology of pertussis

MH Rozenbaum, R De Vries, HH Le… - Epidemiology & …, 2012 - cambridge.org
The aim of this study was to investigate the optimal pertussis booster vaccination strategy for
The Netherlands. A realistic age-structured deterministic model was designed. Assuming a …

Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine (Boostrix™) A Review of its Use as a Single-Dose Booster Immunization

JE Frampton, GM Keating - BioDrugs, 2006 - Springer
Reduced-antigen, combined diphtheria, tetanus, and acellular pertactin-containing pertussis
vaccine (dTpa; Boostrix™) contains reduced quantities of the same toxoids/antigens found …

Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix®) A Review of its Use as a Single-Dose Booster Immunization in …

GL Plosker - BioDrugs, 2009 - Springer
Boostrix® is a three-pertussis component, combined, reduced-antigen content tetanus,
diphtheria, and acellular pertussis (Tdap) booster vaccine administered as a single …

Conclusions on (cost-) effectiveness of pertussis booster vaccination strategies highly dependent on selections made in evidence review

MJ Postma, R de Vries, J Roord - Vaccine, 2009 - Elsevier
This letter reacts on a paper recently published in this journal, reviewing the effectiveness
and (cost-) effectiveness of pertussis booster vaccination strategies. We argue that a …

PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of Pertussis

MH Rozenbaum, MJ Postma, HH Le - Value in Health, 2011 - valueinhealthjournal.com
Objectives To investigate the optimal pertussis booster vaccination strategy for the The
Netherlands and to explore the impact of different assumptions for parameters surrounded …

Οροεπιδημιολογική μελέτη ανοσίας έναντι διφθερίτιδας, τετάνου και κοκκύτη σε δείγμα ελληνικού πληθυσμού

Ε Φουρλάνη - 2010 - didaktorika.gr
Η διφθερίτιδα, ο τέτανος και ο κοκκύτης είναι λοιµώδη νοσήµατα, που χαρακτηρίζονται απó
σηµαντική νοσηρóτητα και θνητóτητα. Αξίζει να σηµειωθεί óτι η διφθερίτιδα αποτελούσε την …

[PDF][PDF] Individually-Based Dynamic Modeling of Infectious Diseases: Cost-Effectiveness of Adolescent Pertussis Vaccination for The Netherlands

R de Vries, M Kretzschmar, JFP Schellekens… - Aimed at Infectious …, 2009 - academia.edu
Background: Despite widespread immunization programs, a clear increase in pertussis
incidence is apparent in many developed countries during the last decades. Consequently …